Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isosorbide Mononitrate for Uterine Artery Doppler Changes in Recurrent Pregnancy Loss
NCT05341856Phase 1Unknown
- Sponsor
- Al-Azhar University
- Start
- May 2022
- Primary completion
- Aug 2022
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in recurrent pregnancy loss (RPL) comparing Isosorbide Mononitrate with Placebo (2 arms). Primary endpoint: Uterine Artery Doppler Changes. Status: unknown.
02
Drugs
isosorbide mononitrate
03
Conditions
recurrent pregnancy loss (RPL)
Beyond the preview
Go deeper on NCT05341856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05341856.